Skip to content

Evaluation, Psychological Intervention and Follow-up Study of Anxiety and Depression in Stable COPD Patients

Evaluation, Psychological Intervention and Follow-up Study of Anxiety and Depression in Stable Chronic Obstructive Pulmonary Disease Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02413840
Enrollment
60
Registered
2015-04-10
Start date
2014-12-31
Completion date
Unknown
Last updated
2015-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, Anxiety, Depression

Keywords

COPD, Baduanjin qigong, depression, anxiety

Brief summary

This study expect to investigate psychological intervention (Baduanjin qigong) in COPD patients combined with anxiety and/or depression.

Detailed description

Anxiety and depression is one of the most common complications of COPD patients.This research use psychological questionnaires to evaluate the stage of COPD patients with anxiety and/or depression(asymptomatic, subclinical,clinical). The subclinical type will divided into the treatment group of Baduanjin qigong,and the control group. Two groups are all receive the same psychological counseling, the treatment group also receive further treatment of Baduanjin qigong under the guidance of medical staff. The treatment along for 1 year. Two groups were followed up for 2 years, dynamically observe the stage of anxiety and depression,the number of exacerbations,lung function,etc.

Interventions

Sponsors

Huimin Gong
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed of COPD * In stable phase * FEV1%predicted \<80.

Exclusion criteria

* Cancer * Severe cerebrovascular disease * Severe arrhythmia,cardiac insufficiency * Alzheimer's disease * Mental illness * Severe liver disfunction * Severe renal disfunction * Physical activity disable.

Design outcomes

Primary

MeasureTime frameDescription
stage of anxiety and depression ((Hospital Anxiety and Depression Scale)one yearuse psychological questionnaires(Hospital Anxiety and Depression Scale,etc)to evaluate the stage of anxiety and/or depression

Secondary

MeasureTime frameDescription
the number of acute exacerbationsone year
lung function (pulmonary function test(20 minutes after inhaled 400ug albuterol),the forced expiratory volume in 1 second(FEV1)will be detected)one yearuse pulmonary function test(20 minutes after inhaled 400ug albuterol),the forced expiratory volume in 1 second(FEV1)will be detected.

Countries

China

Contacts

Primary ContactHuimin Gong
570866508@qq.com8613436379130

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026